Oakmark Global Fund initiated a new position in The Cooper Companies during the second quarter of 2026, citing an attractive entry point after the stock pulled back alongside the broader medical technology sector. The fund noted Cooper's contact lens business benefits from an oligopolistic market structure, high barriers to entry, and recurring revenue, and highlighted the company's track record of market share gains in specialty lenses and its private-label strategy. The stock closed at $68.51 on July 14, 2026, with a market capitalization of $13.36 billion, and the fund believes it trades at a meaningful discount to peers, private market transactions, and its own history.
The Cooper Companies, IncOakmark Global Fund initiated a new position, citing an attractive entry point and discount to peers.